A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam

Campbell, C., McCormack, M., Patel, S., Stapleton, C., Bobbili, D., Krause, R., Depondt, C., Sills, G. J., Koeleman, B. P., Striano, P., Zara, F., Sander, J. W., Lerche, H., Kunz, W. S., Stefansson, K., Stefansson, H., Doherty, C. P., Heinzen, E. L., Scheffer, I. E., … Cavalleri, G. L. (2022). A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam. Epilepsia, 63(6), 1563–1570. Portico. https://doi.org/10.1111/epi.17228
Authors:
Ciarán Campbell
Mark McCormack
Sonn Patel
Caragh Stapleton
Dheeraj Bobbili
Roland Krause
Chantal Depondt
Graeme J. Sills
Bobby P. Koeleman
Pasquale Striano
Federico Zara
Josemir W. Sander
Holger Lerche
Wolfram S. Kunz
Kari Stefansson
Hreinn Stefansson
Colin P. Doherty
Erin L. Heinzen
Ingrid E. Scheffer
David B. Goldstein
Terence O'Brien
David Cotter
Samuel F. Berkovic
Sanjay M. Sisodiya
Norman Delanty
Gianpiero L. Cavalleri
Affiliated Authors:
David B. Goldstein
Columbia Affiliation:
Author Keywords:
adverse drug reactions
levetiracetam
pharmacogenomics
polygenic risk scoring
psychosis
Publication Type:
Article
Unique ID:
10.1111/epi.17228
PMID:
Journal:
Publication Date:
Data Source:
Scopus

Record Created: